The registry is funded by unrestricted grants from four companies: Aimmune, ALK Abello, Allergy Therapeutics and Thermo Fisher.
If you would like to find out more about funding the BRIT Registry please complete the form below.
9 Apr 2024
Announcements,
Latest news,
27 Mar 2024